PE96799A1 - METODOS PARA PRODUCIR UNA SECUENCIA DE ADN UTILIZANDO COMO ENZIMAS DE RESTRICCION HIND III O SpH I - Google Patents

METODOS PARA PRODUCIR UNA SECUENCIA DE ADN UTILIZANDO COMO ENZIMAS DE RESTRICCION HIND III O SpH I

Info

Publication number
PE96799A1
PE96799A1 PE1998000241A PE00024198A PE96799A1 PE 96799 A1 PE96799 A1 PE 96799A1 PE 1998000241 A PE1998000241 A PE 1998000241A PE 00024198 A PE00024198 A PE 00024198A PE 96799 A1 PE96799 A1 PE 96799A1
Authority
PE
Peru
Prior art keywords
plasmids
similar
plasmid
pmtu1
sph
Prior art date
Application number
PE1998000241A
Other languages
English (en)
Inventor
Jorg Hacker
Ulrich Sonnenborn
Jurgen Schulze
Gabriele Blum-Oehler
Jurgen Malinka
Hans Proppert
Original Assignee
Pharma Zentrale Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Zentrale Gmbh filed Critical Pharma Zentrale Gmbh
Publication of PE96799A1 publication Critical patent/PE96799A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A PLASMIDOS DE ENTEROBACTERIAS DE PREFERENCIA DE ESCHERICHIA COLI DSM 6601. LOS PLASMIDOS OBTENIDOS SE SOMETIERON A UN ANALISIS, DETERMINANDOSE QUE EXISTEN DOS PLASMIDOS PEQUENOS DE 3177 PARES DE BASES (pMTU1) Y 5552 PARES DE BASES (pMUT2). SIENDO EL PLASMIDO MENOR (pMTU1) SIMILAR A DISTINTOS SITIOS DE REDUPLICACION DE OTROS PLASMIDOS ENTEROBACTERIANOS, SIMILAR A UN PLASMIDO QUE SE AISLO DE SALMONELLA TYPHIMURIUM. SIENDO EL PLASMIDO MAYOR pMUT2 SIMILAR A LA REGION DE PLASMIDOS CoL.E1 DE E. COLI, SIMILAR A LA REGION DE MOVILIZACION DE PLASMIDOS ColE1, SIMILAR A UN PLASMIDO DE PASTEURELLA-HAEMOLYTICA QUE CODIFICA PROTEINAS DE RESISTENCIA BACTERIANA; POR LO QUE LOS PLASMIDOS pMTU1 Y pMTU2 PUEDEN SER UTILES PARA MEJORAR LAS POSIBILIDADES DE DIAGNOSTICO Y TERAPIA EN ENFERMEDADES POR INFECCIONES CON ENTEROBACTERIAS, EN ANALISIS O DIAGNOSTICO MICROBIOLOGICO, PARA FINES FISIOLOGICOS NUTRICIONALES O PROBIOTICOS Y COMO VECTORES DE EXPRESION EN LA TECNOLOGIA GENETICA
PE1998000241A 1997-04-02 1998-04-02 METODOS PARA PRODUCIR UNA SECUENCIA DE ADN UTILIZANDO COMO ENZIMAS DE RESTRICCION HIND III O SpH I PE96799A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19713543A DE19713543B4 (de) 1997-04-02 1997-04-02 Bakterielle Plasmide

Publications (1)

Publication Number Publication Date
PE96799A1 true PE96799A1 (es) 1999-10-18

Family

ID=7825193

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000241A PE96799A1 (es) 1997-04-02 1998-04-02 METODOS PARA PRODUCIR UNA SECUENCIA DE ADN UTILIZANDO COMO ENZIMAS DE RESTRICCION HIND III O SpH I

Country Status (32)

Country Link
US (1) US6391631B1 (es)
EP (1) EP0975774B1 (es)
JP (2) JP2000514661A (es)
KR (1) KR100398558B1 (es)
CN (2) CN100429313C (es)
AR (1) AR010140A1 (es)
AT (1) ATE277190T1 (es)
AU (1) AU739941B2 (es)
BR (1) BR9808458A (es)
CA (1) CA2285633C (es)
CO (1) CO4790114A1 (es)
CZ (2) CZ294686B6 (es)
DE (2) DE19713543B4 (es)
DK (1) DK0975774T3 (es)
DZ (1) DZ2454A1 (es)
EA (2) EA003700B1 (es)
EE (1) EE04944B1 (es)
ES (1) ES2229492T3 (es)
HK (2) HK1026233A1 (es)
HU (1) HU228182B1 (es)
IL (2) IL132101A0 (es)
NZ (1) NZ338000A (es)
PE (1) PE96799A1 (es)
PL (2) PL192699B1 (es)
PT (1) PT975774E (es)
SI (1) SI0975774T1 (es)
SK (2) SK284929B6 (es)
TR (1) TR199902434T2 (es)
TW (1) TW567225B (es)
UA (1) UA73072C2 (es)
WO (1) WO1998044134A2 (es)
ZA (1) ZA982733B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200000231A (et) * 1997-11-19 2001-06-15 Pharma-Zentrale Gmbh Meetod Escherichia coli tüve DSM 6601 identifitseerimiseks ning DNA järjestused
DE19751242C2 (de) 1997-11-19 2001-02-08 Pharma Zentrale Gmbh DNA-Sequenzen aus Fimbriengenen von Escherichia coli Stamm DSM 6601
DE19915772C2 (de) * 1998-11-18 2001-08-30 Pharma Zentrale Gmbh Verfahren zur Identifizierung von Escherichia coli Stamm DSM 6601
DE10155928A1 (de) * 2001-11-15 2003-06-12 Degussa recA-negativer und rhaB-negativer Mikroorganismus
US7648886B2 (en) * 2003-01-14 2010-01-19 Globalfoundries Inc. Shallow trench isolation process
DE10328669B4 (de) * 2003-06-26 2005-12-01 Pharma-Zentrale Gmbh Plasmidfreier Klon des E. coli Stammes DSM 6601
CN100368549C (zh) * 2006-03-29 2008-02-13 北京未名凯拓作物设计中心有限公司 一种细菌质粒及其衍生质粒与应用
CN106848377B (zh) 2009-08-10 2019-11-08 株式会社Lg 化学 锂二次电池

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843882A (en) * 1995-04-27 1998-12-01 The United States Of America As Represented By The Department Of Health And Human Services Antiviral proteins and peptides
CN1060807C (zh) * 1995-05-25 2001-01-17 中国科学院微生物所 大肠杆菌中表达外源基因的质粒和牛凝乳酶原的生产方法

Also Published As

Publication number Publication date
PL192699B1 (pl) 2006-12-29
CZ294686B6 (cs) 2005-02-16
EE04944B1 (et) 2007-12-17
CZ294867B6 (cs) 2005-04-13
IL132101A0 (en) 2001-03-19
HUP0001857A2 (hu) 2000-10-28
ZA982733B (en) 1998-09-21
JP2003000245A (ja) 2003-01-07
BR9808458A (pt) 2000-05-02
PL192687B1 (pl) 2006-11-30
HK1026233A1 (en) 2000-12-08
CN1253590A (zh) 2000-05-17
CA2285633A1 (en) 1998-10-08
DE59812000D1 (de) 2004-10-28
UA73072C2 (en) 2005-06-15
CN100429313C (zh) 2008-10-29
HK1086596A1 (en) 2006-09-22
CZ348299A3 (cs) 2000-05-17
TR199902434T2 (xx) 2000-01-21
DZ2454A1 (fr) 2003-01-18
SK133899A3 (en) 2000-05-16
EP0975774B1 (de) 2004-09-22
HU228182B1 (en) 2013-01-28
SK284928B6 (sk) 2006-02-02
JP2000514661A (ja) 2000-11-07
SI0975774T1 (en) 2005-02-28
DK0975774T3 (da) 2005-01-31
AR010140A1 (es) 2000-05-17
CN1194093C (zh) 2005-03-23
AU7209598A (en) 1998-10-22
EE9900445A (et) 2000-04-17
ATE277190T1 (de) 2004-10-15
AU739941B2 (en) 2001-10-25
EA199900893A1 (ru) 2001-04-23
SK284929B6 (sk) 2006-02-02
US6391631B1 (en) 2002-05-21
EA003700B1 (ru) 2003-08-28
DE19713543B4 (de) 2007-01-11
NZ338000A (en) 2001-09-28
HUP0001857A3 (en) 2003-07-28
KR20010005924A (ko) 2001-01-15
CA2285633C (en) 2005-10-18
WO1998044134A3 (de) 1999-04-29
EA003738B1 (ru) 2003-08-28
PL336156A1 (en) 2000-06-05
EP0975774A2 (de) 2000-02-02
ES2229492T3 (es) 2005-04-16
EA200000567A1 (ru) 2001-02-26
IL132101A (en) 2006-10-31
KR100398558B1 (ko) 2003-09-19
DE19713543A1 (de) 1998-10-08
WO1998044134A2 (de) 1998-10-08
TW567225B (en) 2003-12-21
CN1727489A (zh) 2006-02-01
CO4790114A1 (es) 1999-05-31
PT975774E (pt) 2005-01-31

Similar Documents

Publication Publication Date Title
DUNN et al. Different template specificities of phage T3 and T7 RNA polymerases
Cheng et al. Cleavage of the cII protein of phage lambda by purified HflA protease: control of the switch between lysis and lysogeny.
DE69826124D1 (de) Verabreichung der nukleinsäure in den quergestreiften muskel
DK0506825T3 (da) Rekombinante ekspressionsvektorer og oprensningsfremgangsmåder til Thermus thermophilus-DNA-polymerase
BR9610511B1 (pt) construções de dna, úteis em terapia genética, compreendendo ao menos uma sequência nucléica de interesse e composição farmacêutica.
ATE361365T1 (de) Streptococcus pneumoniae proteine und nukleinsäuren
DK237979A (da) Fremgangsmaade til fremstilling af proteiner
DK0981630T3 (da) Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme
TR200700740T2 (tr) Nogo genlerinin nükleotid ve protein dizileri ve bunlar bazında yöntemler
HUP0301356A2 (hu) Új, DPPIV-gyel rokon szerin proteáz gének
PE96799A1 (es) METODOS PARA PRODUCIR UNA SECUENCIA DE ADN UTILIZANDO COMO ENZIMAS DE RESTRICCION HIND III O SpH I
PE20010694A1 (es) Plasmido autonomamente reproducible en bacterias corineformes
SE8106641L (sv) Hybrida humanleukocytinterferoner
ATE319818T1 (de) Polypeptide mit aminopeptidaseaktivität und für diese kodierende nukleinsäuren
DE3683267D1 (de) Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung.
Gillen et al. Characterization of the deoxyribonuclease determined by lambda reverse as exonuclease VIII of Escherichia coli
DK1144600T3 (da) Akt-3-nukleinsyre, polypeptider og anvendelser deraf
DE69734586D1 (de) Retinoid-metabolisierendes protein
PT1140023E (pt) Formulacoes cocleares integrativas de proteina-adn e metodos de transformacao celular
JPH0827189A (ja) インターフェロン−γの産生を誘導する蛋白質
JP2666561B2 (ja) 変異型ホタルルシフェラーゼ、変異型ホタルルシフェラーゼ遺伝子、新規な組み換え体dna及び変異型ホタルルシフェラーゼの製造法
Lie et al. Some properties of the lysozymes in serum and colostrum from cows with high and low lytic power against Micrococcus lysodeikticus
YU50900A (sh) Streptomyces avermitilis gen koji usmerava odnos b2:b1 avermektina
Pestka Production and analysis of proteins by recombinant DNA technology
ES2091179T3 (es) Fragmentos de adn de replicacion autonoma, derivados de celulas de mamiferos y que tienen una afinidad respecto a las proteinas que se fijan en el adn.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed